Chanelle Group News and Activities

Chanelle Group is owned by Exponent Private Equity. Exponent Private Equity has a direct presence in 2 countries.

They are in:

• Fund50%
• Pharmaceuticals50%

View the org chart displaying its 13 main executives

Most searched biographies at Chanelle Group

• Angelo Gatto, Chief Executive Officer
• Michael Burke, Chief Financial Officer and Director
• Yvonne Egan, Head of Quality

Popular executive movements at Chanelle Group

• Aubrey Mulveen, Chief Financial Officer, has left the company  (posted on May 21 2026).
• Michael Burke has joined the company as Chief Financial Officer and Director  (posted on May 21 2026).

Create your alert
to follow the executive moves at Chanelle Group.

Exponent Private Equity has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Chanelle Group

• Latest News - Chanelle Pharma

Social media about Chanelle Group

• Chanelle Group on Wikipedia, Google News & Yahoo Finance
• Chanelle Group on LinkedIn, X (Twitter) & YouTube